EOLS Evolus, Inc.
$7.69
Evolus, Inc. (EOLS) Earnings News
Earnings press releases, previews and reviews for Evolus, Inc. (EOLS), newest first.
Wednesday
August 5, 2026
4:05 PM ET
Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook
Tuesday
August 4, 2026
8:30 AM ET
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
Wednesday
July 22, 2026
8:30 AM ET
Evolus to Report Second Quarter Financial Results on August 5, 2026
Wednesday
July 8, 2026
9:00 AM ET
Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality
Monday
May 4, 2026
4:05 PM ET
Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook
Tuesday
April 14, 2026
8:30 AM ET
Evolus to Report First Quarter Financial Results on May 4, 2026